Designing a CXCL8-hsa chimera as potential immunmodulator of the tumor micro-environment.
Saved in:
| Title: | Designing a CXCL8-hsa chimera as potential immunmodulator of the tumor micro-environment. |
|---|---|
| Authors: | Gerlza T; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, Graz, Austria., Trojacher C; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, Graz, Austria., Fuchs T; Medical University Graz, Otto Loewi Research Center, Graz, Austria., Atlic A; Validogen GmbH, Graz, Austria., Weis R; Validogen GmbH, Graz, Austria., Adage T; Antagonis Biotherapeutics GmbH, Graz, Austria., Kungl AJ; Karl-Franzens-University Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, Graz, Austria.; Antagonis Biotherapeutics GmbH, Graz, Austria. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 07; Vol. 16, pp. 1539733. Date of Electronic Publication: 2025 Mar 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1539733 |
